Integra Lifesciences Holdings Corp (IART)
28.89
+0.14
(+0.49%)
USD |
NASDAQ |
May 03, 16:00
28.86
-0.03
(-0.10%)
After-Hours: 20:00
Integra Lifesciences Holdings Cash from Operations (TTM): 139.96M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 139.96M |
| September 30, 2023 | 166.54M |
| June 30, 2023 | 208.08M |
| March 31, 2023 | 246.28M |
| December 31, 2022 | 264.47M |
| September 30, 2022 | 248.41M |
| June 30, 2022 | 262.88M |
| March 31, 2022 | 287.69M |
| December 31, 2021 | 312.43M |
| September 30, 2021 | 323.41M |
| June 30, 2021 | 310.27M |
| March 31, 2021 | 252.10M |
| December 31, 2020 | 203.83M |
| September 30, 2020 | 212.75M |
| June 30, 2020 | 207.36M |
| March 31, 2020 | 222.76M |
| December 31, 2019 | 231.43M |
| September 30, 2019 | 184.94M |
| June 30, 2019 | 199.95M |
| March 31, 2019 | 187.64M |
| December 31, 2018 | 199.68M |
| September 30, 2018 | 168.54M |
| June 30, 2018 | 134.54M |
| March 31, 2018 | 127.19M |
| December 31, 2017 | 114.54M |
| Date | Value |
|---|---|
| September 30, 2017 | 109.52M |
| June 30, 2017 | 111.05M |
| March 31, 2017 | 120.26M |
| December 31, 2016 | 116.40M |
| September 30, 2016 | 135.52M |
| June 30, 2016 | 108.36M |
| March 31, 2016 | 98.26M |
| December 31, 2015 | 104.85M |
| September 30, 2015 | 104.07M |
| June 30, 2015 | 115.54M |
| March 31, 2015 | 103.93M |
| December 31, 2014 | 83.56M |
| September 30, 2014 | 70.40M |
| June 30, 2014 | 70.14M |
| March 31, 2014 | 56.68M |
| December 31, 2013 | 53.27M |
| September 30, 2013 | 38.17M |
| June 30, 2013 | 35.27M |
| March 31, 2013 | 34.63M |
| December 31, 2012 | 59.10M |
| September 30, 2012 | 97.20M |
| June 30, 2012 | 93.08M |
| March 31, 2012 | 115.39M |
| December 31, 2011 | 104.33M |
| September 30, 2011 | 98.06M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
139.96M
Minimum
Dec 2023
323.41M
Maximum
Sep 2021
236.08M
Average
231.43M
Median
Dec 2019
Cash from Operations (TTM) Benchmarks
| Stryker Corp | 3.47B |
| OraSure Technologies Inc | 141.58M |
| Insulet Corp | 145.70M |
| PROCEPT BioRobotics Corp | -104.36M |
| Perspective Therapeutics Inc | -36.91M |